6VWC
Crystal structure of Bcl-xL in complex with tetrahydroisoquinoline-pyridine based inhibitors
Summary for 6VWC
Entry DOI | 10.2210/pdb6vwc/pdb |
Descriptor | Bcl-2-like protein 1, 6-{8-[(1,3-benzothiazol-2-yl)carbamoyl]-3,4-dihydroisoquinolin-2(1H)-yl}-3-{1-[(pyridin-4-yl)methyl]-1H-pyrazol-4-yl}pyridine-2-carboxylic acid (3 entities in total) |
Functional Keywords | bcl-xl inhibitor, apoptosis, structure-based drug design, apoptosis-apoptosis inhibitor complex, apoptosis/apoptosis inhibitor |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 2 |
Total formula weight | 38554.93 |
Authors | Judge, R.A.,Judd, A.S. (deposition date: 2020-02-19, release date: 2020-10-21, Last modification date: 2023-10-11) |
Primary citation | Wang, L.,Doherty, G.A.,Judd, A.S.,Tao, Z.F.,Hansen, T.M.,Frey, R.R.,Song, X.,Bruncko, M.,Kunzer, A.R.,Wang, X.,Wendt, M.D.,Flygare, J.A.,Catron, N.D.,Judge, R.A.,Park, C.H.,Shekhar, S.,Phillips, D.C.,Nimmer, P.,Smith, M.L.,Tahir, S.K.,Xiao, Y.,Xue, J.,Zhang, H.,Le, P.N.,Mitten, M.J.,Boghaert, E.R.,Gao, W.,Kovar, P.,Choo, E.F.,Diaz, D.,Fairbrother, W.J.,Elmore, S.W.,Sampath, D.,Leverson, J.D.,Souers, A.J. Discovery of A-1331852, a First-in-Class, Potent, and Orally-Bioavailable BCL-X L Inhibitor. Acs Med.Chem.Lett., 11:1829-1836, 2020 Cited by PubMed: 33062160DOI: 10.1021/acsmedchemlett.9b00568 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.604 Å) |
Structure validation
Download full validation report